ArticleOncotarget2016

Novel p53-dependent anticancer strategy by targeting iron signaling and BNIP3L-induced mitophagy.

Nastasia Wilfinger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.